glp-1 ncbi Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential The GLP-1 journey: from discovery

Abstracts from the 2022 American Diabetes Association Meeting

With the proper screenplay, their weight loss journey could be worthy of a Best Picture nomination

KD Google 5 stars I had the best experience at Dr

Genetic Predisposition and Personalized GLP-1 Therapy The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR variants that relate to GLP-1 and related signaling pathways

Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses